WO2008154645A1 - Functional abiotic nanosystems - Google Patents
Functional abiotic nanosystems Download PDFInfo
- Publication number
- WO2008154645A1 WO2008154645A1 PCT/US2008/066783 US2008066783W WO2008154645A1 WO 2008154645 A1 WO2008154645 A1 WO 2008154645A1 US 2008066783 W US2008066783 W US 2008066783W WO 2008154645 A1 WO2008154645 A1 WO 2008154645A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- semiconductor
- hetero
- abiotic
- functional
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
Definitions
- the invention relates to methods to modulate the membrane potential of nerve cells upon light stimulation through use of chemically-synthesized functional abiotic nanosystems, and the application thereof to endow light sensitivity to retinal cells such as ganglion cells and bipolar cells and thereby restore lost visual response.
- Degenerative retinopathies such as age-related macular degeneration or retinitis pigmentosa are leading causes of blindness world-wide. Both pathologies involve the loss of function in photoreceptor cells in the retina. As such, partial or complete blindness often results even though the neural wiring connecting the eye to the brain is intact.
- exemplary microelectronics-based macroscopic implants operate similarly to cochlear implants for hearing loss by providing electrode-induced electrical stimulation of the ganglion cells that in turn provide signals to the optic nerve.
- the retinal ganglions so stimulated electrically convey signals to the brain, and thereby afford blind patients limited vision. While encouraging, such macroscopic implants are far from ideal. Physically, they are still very limiting in terms of their size, weight, and external power requirements. Functionally, they are suffer from the problem that the patient's field of vision moves with every head movement.
- US 20030022374 describes an alternative approach in which the photoresponsiveness of the photoreceptors is restored.
- an optical trigger such as a photosystem I reaction center is incorporation into a cell.
- US 20070028928 describes a more general approach involving the localization of nano- and micro-particle solar cells within and among excitable biological cells to control 1 ably regulate membrane polarization of such cells.
- the invention relates to imparting photoreactivity to target cells, e.g., retinal cells, by introducing photoresponsive functional abiotic nanosystems (FANs), nanometer-scale semiconductor/metal or semiconductor/semiconductor hetero- junctions that in this case include a photovoltaic effect.
- FANs photoresponsive functional abiotic nanosystems
- the invention further provides methods of making and using FANs, where the hetero-junctions bear surface functionalization that localizes them in cell membranes. Illumination of these hetero-junctions incorporated in cell membranes generates photovoltages that depolarize the membranes, such as those of nerve cells, in which FANs photogenerate action potentials.
- Figure 1 shows a schematic diagram of an exemplary nanometer-sized semiconductor/metal junction.
- Figure 2 shows a schematic representation of an exemplary band structure of a semiconductor/metal junction (Schottky junction) and its photovoltaic effect.
- Figure 3 shows a schematic representation of semiconductor/metal nanometer-sized hetero-j unction-based FAN with amphiphilic functionalization.
- Figure 4 shows a schematic representation of an exemplary method of inserting FANs into cell plasma membrane through use the of liposomes.
- Figure 5 shows a schematic diagram of a membrane with an embedded nanometer-sized hetero-junction FAN and of the equivalent circuit diagram.
- Figure 6 is a schematic diagram showing FAN embedded into retinal ganglion cell membrane to endow photosensitivity.
- Figure 7 is a schematic representation of the anatomy of the retina, showing its inverted nature. The ganglion cells are closer to the implanted electrodes.
- Figure 8 shows high resolution transmission electron micrographs of two batches of CdSe/Au nanometer-sized semiconductor/metal hetero-junctions before micellar encapsulation.
- Figure 9 depicts the rise of birefringence upon application of external electrical field of CdSe rods, Au/CdSe nanometer-sized hetero-junctions with and without light excitation.
- Figure 10 depicts the fall of birefringence upon removal of external electrical field of CdSe rods, Au/CdSe nanometer-sized hetero-junctions with and without light excitation.
- Figure 11 is a schematic diagram showing an exemplary experimental setup for probing the PV effect of FANs using AFM based surface potential probing (SPP).
- Figure 12 shows measured surface potential change of FAN coated HOPG when light illumination is turned on and off.
- Figure 13 shows an exemplary absorption spectra of Au/CdSe FANs before
- micellar encapsulation micellar encapsulation
- Figure 14 is a schematic diagram showing the ligands covering different facets of an exemplary as-synthesized semiconductor/metal (CdSe/Au) hetero- junctions.
- Figure 15 is schematic diagram showing an exemplary approach to modify surfaces of the semiconductor/metal (CdSe/Au) hetero-junctions.
- plasma membrane and “cell membrane” are used interchangeably throughout to refer to the lipid barrier between the interior and exterior of a eukaryotic cell.
- the present invention introduces photosensitivity into retinal ganglion cells via the attachment or insertion of FANs either across cell membrane or on the outer/inner surface of the cell membrane.
- Figure 1 shows one embodiment of a photoresponsive FAN made of nanometer-sized semiconductor conjoined with a nanometer-sized metal, which together act as a photodiode. The difference in the chemical potentials of the two components (the semi-conductor and the metal) bends the energy bands of the semiconductor near the junction, creating a built-in electrical field. The corresponding schematic band structure of the resulting Schottky junction is shown in Figure 2. Illumination creates electron-hole pairs that separate under the influence of the built-in field, thereby yielding a photovoltage across the structure (the photovoltaic, or PV, effect).
- Figure 3 shows a schematic diagram of the amphiphilic functionalization of a semiconductor/metal hetero-junction, with the metal and semiconductor segments bearing hydrophilic and hydrophobic coatings, respectively.
- FIG. 4 schematically illustrates an exemplary approach in accordance with embodiments of the present invention for introducing a FAN to a retinal ganglion cell through the use of liposomes.
- Figure 5 schematically shows how an FAN localized in a cell membrane, such as that of a ganglion cell, owing to its amphiphilic surface chemistry depolarizes the trans-membrane potential upon absorption of light. Excitation of the FAN with light generates a photovoltage that counteracts the transmembrane potential, triggering an action potential in the cell.
- the lower part of the figure shows the equivalent electronic circuit, with notional values of the electrical parameters of the circuit components.
- Figure 6 shows a schematic diagram of how a FAN embedded into a retinal ganglion cell membrane endows the cell with photosensitivity. Light traverses the anterior structures of the eye until impinging on the retina, where the light strikes retinal ganglion cells. Incorporation of FANs into retinal ganglion cell membranes allows light-induced signals to bypass damaged photoreceptors and generate a ganglion cell action potential triggered by the photovoltaic effect in the FAN.
- Figure 7 shows a detailed schematic view of the anatomy of the posterior region of the eye, including the ganglion cells connecting to the brain. Damaged retinal photoreceptors (rods and cones) are connected via bipolar and amacrine cells to the ganglion cells that transmit visual impulses to the brain. FAN-mediated intracellular stimulation of the ganglion cells bypasses damaged photoreceptors by triggering an action potential in the ganglion cells.
- Figure 8 shows high resolution transmission electron micrographs of two batches of CdSe/Au nanometer-sized semiconductor/metal hetero-junctions of different sizes (left ⁇ 30 nm long; right ⁇ 15 nm long) before micellar encapsulation.
- the Au tip of the rod appears darker than the CdSe end owing to its higher electron density.
- Evenly spaced CdSe lattice planes show that Au growth does not compromise the integrity of the CdSe portion.
- Figure 9 and Figure 10 show the birefringence upon application and removal, respectively of external electrical field of CdSe rods, and of Au/CdSe nanometer- sized hetero-junctions with and without light excitation.
- Figure 11 is a schematic showing the experimental setup used to probe the photovoltaic effect of FANs using atomic force microscopy based surface potential probing (SPP).
- SPP surface potential probing
- Figure 12 shows the measured surface potential change of FAN coated HOPG substrate under illumination of 532nm laser chopped at 10Hz. A surface potential difference of ⁇ 15mV was observed when illumination is turned on and off. This difference may be attributed to the photovoltaic effect of the FANs.
- Figure 13 shows the optical absorption , spectra of CdSe/Au FANs as synthesized (in toluene), and in phosphate-buffered saline after functional ization, showing that the optical properties of the FANs remain largely unchanged by the derivatization procedure.
- FIG 14 schematically shows the CdSe/Au rods as synthesized, when they are covered by trioctylphosphine oxide and alkylphosphonic acid (both of which are hydrophobic).
- FIG. 15 schematically illustrates that, after surface functionalization with polyethylene glycol, the surface of the Au portion of the CdSe/Au FAN is hydrophilic, while the CdSe end, still covered by trioctylphosphine oxide and alkyl phosphonic acid, remains hydrophobic.
- Illumination of photovoltaic FANs embedded into a nerve cell membrane changes the potential across the nerve cell membrane by -10 mV and thereby triggers the firing of an action potential.
- US 20030022374 discloses that illumination of spinach photosystem I particles (-50 nm in size), delivered to retinoblastoma cells through the use of proteoliposome vesicles, changes the Ca 2+ concentration gradient across the plasma membrane of the cells.
- US 20070028928 also incorporated by reference in its entirety describes methods of using nanoparticle solar cells to regulate the membrane polarization of excitable biological cells.
- Placement and stabilization of the photovoltaic FAN actuators in the membrane mimics the naturally-occurring amphiphilic trans-membrane proteins, which have hydrophobic membrane-spanning domain(s) that interact with fatty acyl groups of the membrane phospholipids and hydrophilic domains extending into the aqueous medium on each side of the membrane.
- Nanometer-sized semiconductor/metal hetero-junction FANs have different surface chemistry at the metal and semiconductor components. This allows the two to be functionalized separately with hydrophilic and hydrophobic compounds (Figure 3), thus making them amphiphilic for trans-membrane anchoring.
- Photovoltaic FAN modulation of nerve cell trans-membrane potential, and inducing firing of action potential [0044] Illumination of photovoltaic FANs embedded in nerve cell membranes triggers the firing of the nerve cell action potential.
- a cell with an embedded semiconductor/metal FAN can be approximated electrically by the circuit diagram shown in Figure 5 (lower portion).
- Membranes typically average ⁇ 5 nm in thickness and act as a capacitor (capacitance CM ⁇ 1 ⁇ F/cm 2 ).
- An embedded semiconductor/metal FAN (with the metal inside the cell) acts as a photovoltaic cell, which is electrically equivalent to a current source with a resistor and a capacitor in parallel ( Figure 5, lower portion), with the parallel resistor representing the internal resistance within the FAN.
- the electric current varies with the rate of photon absorption.
- the connection between the FAN and the membrane is mediated by the motion of ions in the solution, which is represented by a series resistor between the FAN and the membrane.
- Illumination of embedded photovoltaic FANs generate a photovoltage that reduces the potential across the ganglion cell membrane by -10 mV.
- Such membrane depolarization causes enough voltage-sensitive Na + ion channels to open to generate an action potential that travels down the axon.
- a typical FAN consists of a 5 nm diameter gold tip grown on a 10 nm diameter CdSe nanorod and embedded in the membrane at a density of 10 10 /cm 2 . Since the FAN occupies only 1% of the membrane area, its capacitance is much smaller than that of the membrane. Such a FAN has -10 nm 2 absorption cross-section for visible light.
- FANs can be constructed from a variety of other semiconductor/metal and semiconductor/semiconductor hetero-junctions.
- FANs based upon semiconductor/metal hetero-junctions between group II- VI, IV, III- V, IV-VI (referring to groups of the periodic table), metal-oxide, or organic semiconductors and a metal and in particular those based upon Si/Au, GaAs/Au, InAs/Au, and PbS/Au hetero-junctions, can be used in the same way as those discussed here.
- Figure 8 shows high-resolution transmission electron microscopy images
- CdSe/Au nanometer-sized semiconductor/metal hetero-junctions Both CdSe and gold nanocrystals have individually been widely applied in biological labeling in cells, tissues, and animals. Integration of both CdSe and Au into one nanometer- sized composite leads to nanoscale Schottky diodes.
- CdSe/Au integrated nanometer-sized composites are synthesized through a two-step procedure.
- CdSe nanorods were formed by the reaction of Cd and Se precursors in a mixture of trioctylphosphine oxide and an alkylphosphonic acid. Due to the Wurtzite crystallographic structure of the CdSe, (001) and (00 1) facets of the CdSe have enhanced chemical reactivity compared to the ⁇ 011 ⁇ facets, therefore rod-shaped CdSe nanoparticles (elongated along (001) direction) can be formed.
- the CdSe rods suspension is treated with a mixture of gold chloride, didodecyldimethyl-ammonium bromide, and hexadecylamine to stabilize the nanocrystals and to reduce the gold chloride to elemental gold.
- the dark end of the rod corresponds to the Au tip, which has higher electron density than the CdSe end.
- the particle size ( ⁇ 2 nm to > 100 nm), aspect ratio (1 :1 to > 1:30) or shape (rod, tetrapod) can be varied over a wide range by controlling growth conditions.
- Transient electrical birefringence measurements confirm the photovoltaic effect in the CdSe/Au nanometer-sized semiconductor/metal hetero-j unctions.
- CdSe rods exhibit optical birefringence owing to their anisotropy.
- Transient electrical birefringence measurements entail measuring the rise ( ⁇ n r ) and fall ( ⁇ n f ) of the birefringence of the CdSe rods or CdSe/Au nanometer-sized heterojunctions (suspended in a liquid) in response to the imposition and removal of an external electric field.
- the rising edge of the birefringence of the rods reflects the rotation of nanometer-sized hetero-junctions to align its dipole preferentially with the external field.
- the falling edge the slope of which gives the rotational diffusion constant of the rods, reflects the randomization of the rod orientation on removal of the external field. CdSe/Au samples of large aspect ratio were used to achieve sufficient transient electrical birefringence signal.
- Figure 9 shows the rising and Figure 10 falling edge of the transient birefringence for three cases: CdSe rods before Au tip growth, and CdSe/Au heterojunctions with and without excitation. Excitation was via continuous 532 nm laser at 1 W/cm 2 . Heating by the excitation laser was considered and ruled out. Compared to CdSe rods, the fall and rise of CdSe/Au birefringence is -20 times slower. Moreover, CdSe/Au samples in dark and under 532nm illumination exhibited significantly different transient electrical birefringence. This different rotational response to an external electric field is consistent with photoexcitation redistributing charge in individual CdSe/Au nanometer-sized semiconductor/metal hetero-j unctions, and therefore with a photovoltaic effect.
- the photovoltaic effect of the CdSe/Au FAN is also independently checked using atomic force microscopy (AFM) based surface potential probing (SPP) as schematically shown in Figure 11.
- AFM atomic force microscopy
- SPP surface potential probing
- the HOPG surface gets coated with a layer of FANs that statistically acquire a preferred orientation along the electrical field perpendicular to the surface.
- Platinum Iridium-coated conducting AFM tip was used to measure the surface potential (V SU rface) of CdSe/Au FAN coated HOPG substrate under light excitation as briefly described below (refer to Figure 11).
- the AFM tip was lifted a certain height ( ⁇ 60nm) above the surface of the sample.
- the surface potential (V sur face) was then measured by adjusting V DC to be equal to V sur f ace via a feedback loop so that the force between the tip and surface at frequency ⁇ was zeroed (hence the oscillation of the tip is minimized).
- the FAN coated HOPG sample was excited by a 532nm laser chopped at lOHz.
- the measured surface potential is shown in Figure 12.
- the difference in the surface potential as the light excitation is turned on and off is around 15mV. This difference can most likely be attributed to the photovoltaic effect of the CdSe/Au FANs on the HOPG surface, since no measurable surface potential change as a function of light excitation was observed on either bare HOPG or HOPG surface deposited with CdSe rods.
- Synthesis of the colloidal FANs preferably uses non-polar solvents such as toluene, whereas their use in vivo necessitates ultimately exposing them to water.
- Encapsulation of the FANs in phospholipid block-copolymer micelles composed of n-poly(ethylene glycol) phosphatidylethanolamine (PEG-PE) and phosphatidylcholine protected the FANs and thereby rendered them compatible with phosphate-buffered saline solution.
- PEG-PE n-poly(ethylene glycol) phosphatidylethanolamine
- US 7041371 describes methodology for coating the surfaces of semiconductor nanoparticles with polyethylene glycol.
- Figure 13 shows the measured optical density of the as-synthesized FAN in toluene and then converted to soluble in phosphate-buffered saline for normalized concentration. Similar phospholipid micelle encapsulation of CdSe-based semiconductor quantum dots for in vitro and in vivo imaging applications rendered them stable in physiological solution and non-toxic to cells up to concentrations of 5xlO 9 per dots/cell.
- the rods are characterized through use of transmission electron microscopy.
- Varying the Se pre-cursor injection volume and concentration, the injection temperature, and the molar ratio of the trioctylphosphine oxide(TOPO):hexylphosphonic acid (HPA) :octadecylphosphonic acid (ODPA) allows control over the length and width of the rods.
- TOPO trioctylphosphine oxide
- HPA hexylphosphonic acid
- ODPA octadecylphosphonic acid
- the Au/CdSe nanocrystal semiconductor/metal junction was formed by growing Au tips on one end of the CdSe rods.
- a stock solution of gold salts was prepared by dissolving AuCl 3 (1.66 mg), didodecyldimethyl ammonium bromide (8.33 mg), and hexyldecylamine (15 mg) in toluene (1 g).
- the as-synthesized Au/CdSe rods were characterized through use of transmission electron microscopy.
- the majority (>75%) of Au/CdSe rods synthesized by the procedure outline above are asymmetric with only a single Au tip on the CdSe rod.
- the CdSe/Au rods are covered by trioctylphosphine oxide and alkylphosphonic acid (both of which are hydrophobic), as shown in Figure 14.
- Surface functionalization covers the Au tips of the CdSe/Au rods with polyethylene glycol, making them hydrophilic; the CdSe end, still covered by trioctylphosphine oxide and alkyl phosphonic acid, remains hydrophobic ( Figure 15).
- the CdSe/Au nanojunctions are amphiphilic and compatible with bilipid membranes.
- CdSe/Au (-0.1 mg/mL) nanojunctions are suspended in N,N- dimethylformamide containing detergent (e.g., 1% Triton X-IOO) and exposed to polyethylene glyco!-(CH 2 ) ⁇ o-SH ( ⁇ 1 mM) at room temperature for about an hour under stir to coordinate the thiol to the Au end.
- the Au/CdSe rods are separated from the solution through use of spin-filtration (filter pore size -1OkDa). The separated FANs are redissolved in phosphate buffered saline containing Triton X-IOO.
- Liposomes are prepared sonicating a commercially-available mixture of phosphatidyl choline/cholesterol/phosphatidyl glycerol/phosphatidyl inositol (in 8:10:1:1:2 molar ratio) in aqueous buffer (e.g., 20 mM sodium phosphate, 0.15 M NaCl, pH 7.4) at room temperature.
- aqueous buffer e.g., 20 mM sodium phosphate, 0.15 M NaCl, pH 7.4
- Amphiphilically functionalized CdSe/Au FANs are inserted into the liposomes through first de-stabilizing the preformed liposomes with a detergent (e.g., 1% Triton X-100), followed by addition of amphiphilic CdSe/Au FANs to the destabilized liposome suspension.
- the CdSe/Au FAN-containing liposomes are then reconstituted by gel-chromatography (through use of for example Sepharose 4B column in 20 mM sodium phosphate, 0.15 M NaCl, pH 7.4 buffer).
- the liposome size is characterized through use of dynamic light scattering, while the orientation and density of the FANs in the liposome are characterized through use of transmission electron microscopy. Conjugation of antibody to the liposome
- liposomes to cells (e.g. retina ganglion cells) with specific surface receptors (e.g. retina ganglion cell specific Thy-1 receptor), is achieved by conjugating the liposome to the corresponding antibodies by the following procedure, in which the amine terminus of the heavy chain of the antibody is linked to the phosphatidyl glycerol component of the liposome via reductive amination-mediated conjugation technique as detailed in the following two steps.
- cells e.g. retina ganglion cells
- specific surface receptors e.g. retina ganglion cell specific Thy-1 receptor
- oxidized liposomes are dialyzed against 20 mM sodium borate, 0.15 M NaCl pH 8.4 to remove the unreacted periodate.
- the liposome suspension is further purified through use of a column of Sephadex G-50.
- the present invention clearly can be used to introduce photoresponsiveness to a wide variety of cells, and thereby not only to restore lost function but to impart new function to such cells.
- photoresponsiveness can be introduced to cells not normally responsive to light, and/or the range of photoresponsiveness can be extended beyond normally visible wavelengths (to, e.g., the near infrared).
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to imparting photoreactivity to target cells, e.g., retinal cells, by introducing photoresponsive functional abiotic nanosystems (FANs), nanometer-scale semiconductor/metal or semiconductor/semiconductor hetero-junctions that in this case include a photovoltaic effect. The invention further provides methods of making and using FANs, where the hetero-junctions bear surface functionalization that localizes them in cell membranes. Illumination of these hetero-junctions incorporated in cell membranes generates photovoltages that depolarize the membranes, such as those of nerve cells, in which FANs photogenerate action potentials. Incorporating FANs into the cells of a retina with damaged photoreceptor cells reintroduces photoresponsiveness to the retina, so that light creates action potentials that the brain interprets as sight.
Description
FUNCTIONAL ABIOTIC NANOSYSTEMS
STATEMENT OF FEDERALLY SPONSORED RESEARCHAND DEVELOPMENT
[0001] The U.S. Government has certain rights in this invention pursuant to grant number EEC-0310723, awarded by the National Science Foundation, Engineering Research Centers Program and AFOSR 49620-01-0474 awarded by the Department of Defense.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of U.S Provisional Application Number
60/943,360, filed June 12, 2007, entitled "FUNCTIONAL ABIOTIC NANOSYSTEMS". The benefit under 35 USC §119(e) of the United States provisional application is hereby claimed. The above priority application is hereby incorporated herein by reference.
FIELD OF THE INVENTION
[0003] The invention relates to methods to modulate the membrane potential of nerve cells upon light stimulation through use of chemically-synthesized functional abiotic nanosystems, and the application thereof to endow light sensitivity to retinal cells such as ganglion cells and bipolar cells and thereby restore lost visual response.
BACKGROUND OF THE INVENTION
[0004] Degenerative retinopathies such as age-related macular degeneration or retinitis pigmentosa are leading causes of blindness world-wide. Both pathologies involve the loss of function in photoreceptor cells in the retina. As such, partial or complete blindness often results even though the neural wiring connecting the eye to the brain is intact.
[0005] Accordingly, one approach to overcome blindness has been focusing on the development of photosensitive implants to bypass the damaged photoreceptors in blind patients. Exemplary microelectronics-based macroscopic implants operate similarly to cochlear implants for hearing loss by providing electrode-induced
electrical stimulation of the ganglion cells that in turn provide signals to the optic nerve. The retinal ganglions so stimulated electrically convey signals to the brain, and thereby afford blind patients limited vision. While encouraging, such macroscopic implants are far from ideal. Physically, they are still very limiting in terms of their size, weight, and external power requirements. Functionally, they are suffer from the problem that the patient's field of vision moves with every head movement.
[0006] US 20030022374 describes an alternative approach in which the photoresponsiveness of the photoreceptors is restored. In this approach, an optical trigger such as a photosystem I reaction center is incorporation into a cell.
[0007] US 20070028928 describes a more general approach involving the localization of nano- and micro-particle solar cells within and among excitable biological cells to control 1 ably regulate membrane polarization of such cells.
[0008] Presently, no treatment is available for restoring vision lost to retinitis pigmentosa or age-related macular degeneration. Thus, there still exists an unmet need for a way to treat such debilitating diseases.
SUMMARY OF THE INVENTION
[0009] The invention relates to imparting photoreactivity to target cells, e.g., retinal cells, by introducing photoresponsive functional abiotic nanosystems (FANs), nanometer-scale semiconductor/metal or semiconductor/semiconductor hetero- junctions that in this case include a photovoltaic effect. The invention further provides methods of making and using FANs, where the hetero-junctions bear surface functionalization that localizes them in cell membranes. Illumination of these hetero-junctions incorporated in cell membranes generates photovoltages that depolarize the membranes, such as those of nerve cells, in which FANs photogenerate action potentials. Incorporating FANs into the cells of a retina with damaged photoreceptor cells reintroduces photoresponsiveness to the retina, so that light creates action potentials that the brain interprets as sight.
[0010] Other aspects and advantages of the invention will be apparent from the following description and the appended claims.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 shows a schematic diagram of an exemplary nanometer-sized semiconductor/metal junction.
[0012] Figure 2 shows a schematic representation of an exemplary band structure of a semiconductor/metal junction (Schottky junction) and its photovoltaic effect.
[0013] Figure 3 shows a schematic representation of semiconductor/metal nanometer-sized hetero-j unction-based FAN with amphiphilic functionalization.
[0014] Figure 4 shows a schematic representation of an exemplary method of inserting FANs into cell plasma membrane through use the of liposomes.
[0015] Figure 5 shows a schematic diagram of a membrane with an embedded nanometer-sized hetero-junction FAN and of the equivalent circuit diagram.
[0016] Figure 6 is a schematic diagram showing FAN embedded into retinal ganglion cell membrane to endow photosensitivity.
[0017] Figure 7 is a schematic representation of the anatomy of the retina, showing its inverted nature. The ganglion cells are closer to the implanted electrodes.
[0018] Figure 8 shows high resolution transmission electron micrographs of two batches of CdSe/Au nanometer-sized semiconductor/metal hetero-junctions before micellar encapsulation.
[0019] Figure 9 depicts the rise of birefringence upon application of external electrical field of CdSe rods, Au/CdSe nanometer-sized hetero-junctions with and without light excitation.
[0020] Figure 10 depicts the fall of birefringence upon removal of external electrical field of CdSe rods, Au/CdSe nanometer-sized hetero-junctions with and without light excitation.
[0021] Figure 11 is a schematic diagram showing an exemplary experimental setup for probing the PV effect of FANs using AFM based surface potential probing (SPP).
[0022] Figure 12 shows measured surface potential change of FAN coated HOPG when light illumination is turned on and off.
[0023] Figure 13 shows an exemplary absorption spectra of Au/CdSe FANs before
(in toluene) and after (dissolved in phosphate-buffered saline solution) micellar encapsulation.
[0024] Figure 14 is a schematic diagram showing the ligands covering different facets of an exemplary as-synthesized semiconductor/metal (CdSe/Au) hetero- junctions.
[0025] Figure 15 is schematic diagram showing an exemplary approach to modify surfaces of the semiconductor/metal (CdSe/Au) hetero-junctions.
DETAILED DESCRIPTION
[0026] Unless otherwise specified, technical terms here take their usual meanings, specifically those specified in the McGraw-Hill Dictionary of Scientific and Technical Terms, 6th edition. The terms "plasma membrane" and "cell membrane" are used interchangeably throughout to refer to the lipid barrier between the interior and exterior of a eukaryotic cell.
[0027] The present invention introduces photosensitivity into retinal ganglion cells via the attachment or insertion of FANs either across cell membrane or on the outer/inner surface of the cell membrane. Figure 1 shows one embodiment of a photoresponsive FAN made of nanometer-sized semiconductor conjoined with a nanometer-sized metal, which together act as a photodiode. The difference in the chemical potentials of the two components (the semi-conductor and the metal) bends the energy bands of the semiconductor near the junction, creating a built-in electrical field. The corresponding schematic band structure of the resulting Schottky junction is shown in Figure 2. Illumination creates electron-hole pairs that separate under
the influence of the built-in field, thereby yielding a photovoltage across the structure (the photovoltaic, or PV, effect).
[0028] Figure 3 shows a schematic diagram of the amphiphilic functionalization of a semiconductor/metal hetero-junction, with the metal and semiconductor segments bearing hydrophilic and hydrophobic coatings, respectively.
[0029] Figure 4 schematically illustrates an exemplary approach in accordance with embodiments of the present invention for introducing a FAN to a retinal ganglion cell through the use of liposomes. After incorporation of amphiphilic FANs into a bilayer membrane of a liposome, assimilation of the liposome into a cell membrane delivers the FANs into that membrane, with the hydrophobic portion of each FAN immersed in the lipid portion of the membrane, and the hydrophilic extending into the aqueous phase.
[0030] Figure 5 schematically shows how an FAN localized in a cell membrane, such as that of a ganglion cell, owing to its amphiphilic surface chemistry depolarizes the trans-membrane potential upon absorption of light. Excitation of the FAN with light generates a photovoltage that counteracts the transmembrane potential, triggering an action potential in the cell. The lower part of the figure shows the equivalent electronic circuit, with notional values of the electrical parameters of the circuit components.
[0031] Figure 6 shows a schematic diagram of how a FAN embedded into a retinal ganglion cell membrane endows the cell with photosensitivity. Light traverses the anterior structures of the eye until impinging on the retina, where the light strikes retinal ganglion cells. Incorporation of FANs into retinal ganglion cell membranes allows light-induced signals to bypass damaged photoreceptors and generate a ganglion cell action potential triggered by the photovoltaic effect in the FAN.
[0032] Figure 7 shows a detailed schematic view of the anatomy of the posterior region of the eye, including the ganglion cells connecting to the brain. Damaged retinal photoreceptors (rods and cones) are connected via bipolar and amacrine cells to the ganglion cells that transmit visual impulses to the brain. FAN-mediated
intracellular stimulation of the ganglion cells bypasses damaged photoreceptors by triggering an action potential in the ganglion cells.
[0033] Figure 8 shows high resolution transmission electron micrographs of two batches of CdSe/Au nanometer-sized semiconductor/metal hetero-junctions of different sizes (left ~30 nm long; right ~15 nm long) before micellar encapsulation. The Au tip of the rod appears darker than the CdSe end owing to its higher electron density. Evenly spaced CdSe lattice planes show that Au growth does not compromise the integrity of the CdSe portion.
[0034] Figure 9 and Figure 10 show the birefringence upon application and removal, respectively of external electrical field of CdSe rods, and of Au/CdSe nanometer- sized hetero-junctions with and without light excitation.
[0035] Figure 11 is a schematic showing the experimental setup used to probe the photovoltaic effect of FANs using atomic force microscopy based surface potential probing (SPP).
[0036] Figure 12 shows the measured surface potential change of FAN coated HOPG substrate under illumination of 532nm laser chopped at 10Hz. A surface potential difference of ~15mV was observed when illumination is turned on and off. This difference may be attributed to the photovoltaic effect of the FANs.
[0037] Figure 13 shows the optical absorption , spectra of CdSe/Au FANs as synthesized (in toluene), and in phosphate-buffered saline after functional ization, showing that the optical properties of the FANs remain largely unchanged by the derivatization procedure.
[0038] Figure 14 schematically shows the CdSe/Au rods as synthesized, when they are covered by trioctylphosphine oxide and alkylphosphonic acid (both of which are hydrophobic).
[0039] Figure 15 schematically illustrates that, after surface functionalization with polyethylene glycol, the surface of the Au portion of the CdSe/Au FAN is hydrophilic, while the CdSe end, still covered by trioctylphosphine oxide and alkyl phosphonic acid, remains hydrophobic.
[0040] Illumination of photovoltaic FANs embedded into a nerve cell membrane changes the potential across the nerve cell membrane by -10 mV and thereby triggers the firing of an action potential. US 20030022374 (hereby incorporated by reference in its entirety) discloses that illumination of spinach photosystem I particles (-50 nm in size), delivered to retinoblastoma cells through the use of proteoliposome vesicles, changes the Ca2+ concentration gradient across the plasma membrane of the cells. US 20070028928 (also incorporated by reference in its entirety) describes methods of using nanoparticle solar cells to regulate the membrane polarization of excitable biological cells.
Incorporation of photovoltaic FANs into cell membranes
[0041] Placement and stabilization of the photovoltaic FAN actuators in the membrane mimics the naturally-occurring amphiphilic trans-membrane proteins, which have hydrophobic membrane-spanning domain(s) that interact with fatty acyl groups of the membrane phospholipids and hydrophilic domains extending into the aqueous medium on each side of the membrane. Nanometer-sized semiconductor/metal hetero-junction FANs have different surface chemistry at the metal and semiconductor components. This allows the two to be functionalized separately with hydrophilic and hydrophobic compounds (Figure 3), thus making them amphiphilic for trans-membrane anchoring.
[0042] Delivery of the nanometer-sized hetero-junction photovoltaic FAN to targeted cells and other locations is achieved through the use of liposomes (Figure 4). Amphiphilically-functionalized FANs are incorporated into phosphilipid liposomes through the use of standard procedures. When the liposomes are fused with the cells, the nanometer-sized hetero-junction are inserted into the cell plasma membrane. Furthermore, functionalizing the liposome with Iipid-anchored ligands binds to the specific surface receptors on different types of ganglion cells. Appropriate vesicle fusion proteins may be included in the liposomes to effect more efficient fusion with the cell membrane.
[0043] Photovoltaic FAN modulation of nerve cell trans-membrane potential, and inducing firing of action potential
[0044] Illumination of photovoltaic FANs embedded in nerve cell membranes triggers the firing of the nerve cell action potential. A cell with an embedded semiconductor/metal FAN can be approximated electrically by the circuit diagram shown in Figure 5 (lower portion). Membranes typically average ~5 nm in thickness and act as a capacitor (capacitance CM ~1 μF/cm2). Membrane ion channels (mainly resting K+ channels) exert a typical resistivity of Rk = 10 kΩ-cm2. The ionic gradient across the membrane, created by ATP driven ion-transporters, generates an electromotive potential (resting potential) inside the cell -60 mV less than that outside.
[0045] An embedded semiconductor/metal FAN (with the metal inside the cell) acts as a photovoltaic cell, which is electrically equivalent to a current source with a resistor and a capacitor in parallel (Figure 5, lower portion), with the parallel resistor representing the internal resistance within the FAN. The electric current varies with the rate of photon absorption. The connection between the FAN and the membrane is mediated by the motion of ions in the solution, which is represented by a series resistor between the FAN and the membrane.
[0046] Illumination of embedded photovoltaic FANs generate a photovoltage that reduces the potential across the ganglion cell membrane by -10 mV. Such membrane depolarization causes enough voltage-sensitive Na+ ion channels to open to generate an action potential that travels down the axon.
[0047] The density of FANs and the light flux to create the -10 mV membrane depolarization can be estimated as follows. A typical FAN consists of a 5 nm diameter gold tip grown on a 10 nm diameter CdSe nanorod and embedded in the membrane at a density of 1010/cm2. Since the FAN occupies only 1% of the membrane area, its capacitance is much smaller than that of the membrane. Such a FAN has -10 nm2 absorption cross-section for visible light.
[0048] For every photogenerated electron-hole separation across the plasma membrane (and assuming no electron-hole recombination, i.e., Rparaiiei » RK + Rseriai), generation of one action potential (by charging the membrane 10 mV) every second entails 10'8 C/cm2 charge displacement across the membrane per second.
[0049] This in turn implies 0.02 mW/cm2 light power density impinging on the membrane of retinal ganglion cells. In typical human eyes only 20% of the incident light reaches the retina. Therefore to achieve 0.02 mW/cm2 power density impinging on the retina, an eye with 4 mm pupil aperture needs to look at a light source of brightness 20,000 Cd/m2. For reference objects in direct sunlight have typical brightness on the order of ~50,000 Cd/m2.
[0050] Having generally described this invention, a further understanding can be obtained by reference to certain specific examples which are provided herein for purposes of illustration only and are not intended to be limiting unless otherwise specified.
[0051] The examples that follow focus on the use of CdSe/Au hetero-junctions for the sake of concreteness, but it will be readily appreciated by those skilled in the relevant art that FANs can be constructed from a variety of other semiconductor/metal and semiconductor/semiconductor hetero-junctions. For example, FANs based upon semiconductor/metal hetero-junctions between group II- VI, IV, III- V, IV-VI (referring to groups of the periodic table), metal-oxide, or organic semiconductors and a metal, and in particular those based upon Si/Au, GaAs/Au, InAs/Au, and PbS/Au hetero-junctions, can be used in the same way as those discussed here.
EXAMPLES
[0052] Figure 8 shows high-resolution transmission electron microscopy images of
CdSe/Au nanometer-sized semiconductor/metal hetero-junctions. Both CdSe and gold nanocrystals have individually been widely applied in biological labeling in cells, tissues, and animals. Integration of both CdSe and Au into one nanometer- sized composite leads to nanoscale Schottky diodes.
[0053] The CdSe/Au integrated nanometer-sized composites are synthesized through a two-step procedure. First, CdSe nanorods were formed by the reaction of Cd and Se precursors in a mixture of trioctylphosphine oxide and an alkylphosphonic acid. Due to the Wurtzite crystallographic structure of the CdSe, (001) and (00 1) facets of the CdSe have enhanced chemical reactivity compared to the {011} facets,
therefore rod-shaped CdSe nanoparticles (elongated along (001) direction) can be formed.
[0054] Second, the CdSe rods suspension is treated with a mixture of gold chloride, didodecyldimethyl-ammonium bromide, and hexadecylamine to stabilize the nanocrystals and to reduce the gold chloride to elemental gold.
[0055] Because the two ends ( (001) vs. (00 T) facets) of the CdSe rods differ crystallographically (and hence chemically), careful control of growth conditions allows growth of Au particles preferentially on one end of each rod.
]0056] In Figure 8 the dark end of the rod corresponds to the Au tip, which has higher electron density than the CdSe end. The particle size (< 2 nm to > 100 nm), aspect ratio (1 :1 to > 1:30) or shape (rod, tetrapod) can be varied over a wide range by controlling growth conditions.
Photovoltaic FANs
[0057] Transient electrical birefringence measurements confirm the photovoltaic effect in the CdSe/Au nanometer-sized semiconductor/metal hetero-j unctions. CdSe rods exhibit optical birefringence owing to their anisotropy. Transient electrical birefringence measurements entail measuring the rise (Δnr) and fall (Δnf) of the birefringence of the CdSe rods or CdSe/Au nanometer-sized heterojunctions (suspended in a liquid) in response to the imposition and removal of an external electric field. The rising edge of the birefringence of the rods reflects the rotation of nanometer-sized hetero-junctions to align its dipole preferentially with the external field. The falling edge, the slope of which gives the rotational diffusion constant of the rods, reflects the randomization of the rod orientation on removal of the external field. CdSe/Au samples of large aspect ratio were used to achieve sufficient transient electrical birefringence signal.
[0058] Figure 9 shows the rising and Figure 10 falling edge of the transient birefringence for three cases: CdSe rods before Au tip growth, and CdSe/Au heterojunctions with and without excitation. Excitation was via continuous 532 nm laser at 1 W/cm2. Heating by the excitation laser was considered and ruled out. Compared to CdSe rods, the fall and rise of CdSe/Au birefringence is -20 times
slower. Moreover, CdSe/Au samples in dark and under 532nm illumination exhibited significantly different transient electrical birefringence. This different rotational response to an external electric field is consistent with photoexcitation redistributing charge in individual CdSe/Au nanometer-sized semiconductor/metal hetero-j unctions, and therefore with a photovoltaic effect.
Probing FAN Photovoltaic effect using AFM based surface potential probing
[0059] The photovoltaic effect of the CdSe/Au FAN is also independently checked using atomic force microscopy (AFM) based surface potential probing (SPP) as schematically shown in Figure 11. To prepare the sample for this measurement, a drop of CdSe/Au FAN solution in toluene was put onto a freshly cleaved surface of highly ordered pyro lytic graphite (HOPG) and placed in an constant electrical field of ~lxl O4 V/cm perpendicular to the HOPG surface. Since the CdSe/Au FANs have built-in electrical dipole, as the FAN solution slowly dries (over ~ 1 hour), the HOPG surface gets coated with a layer of FANs that statistically acquire a preferred orientation along the electrical field perpendicular to the surface.
[0060] The sample was then installed on a Digital Instrument Multimode AFM and an
Platinum Iridium-coated conducting AFM tip was used to measure the surface potential (VSUrface) of CdSe/Au FAN coated HOPG substrate under light excitation as briefly described below (refer to Figure 11). The AFM tip was lifted a certain height (~60nm) above the surface of the sample. A voltage V(t) = VDc + VAc"sin(ωt) was applied on the AFM tip (where ω is the resonant frequency of the tip) to create an oscillating electrical force between the tip and the surface. The surface potential (Vsurface) was then measured by adjusting VDC to be equal to Vsurface via a feedback loop so that the force between the tip and surface at frequency ω was zeroed (hence the oscillation of the tip is minimized).
[0061] In our measurements, the FAN coated HOPG sample was excited by a 532nm laser chopped at lOHz. The measured surface potential is shown in Figure 12. The difference in the surface potential as the light excitation is turned on and off is around 15mV. This difference can most likely be attributed to the photovoltaic effect of the CdSe/Au FANs on the HOPG surface, since no measurable surface
potential change as a function of light excitation was observed on either bare HOPG or HOPG surface deposited with CdSe rods.
Rendering FANs Water-Compatible
[0062] Synthesis of the colloidal FANs preferably uses non-polar solvents such as toluene, whereas their use in vivo necessitates ultimately exposing them to water. Encapsulation of the FANs in phospholipid block-copolymer micelles composed of n-poly(ethylene glycol) phosphatidylethanolamine (PEG-PE) and phosphatidylcholine protected the FANs and thereby rendered them compatible with phosphate-buffered saline solution. US 7041371 describes methodology for coating the surfaces of semiconductor nanoparticles with polyethylene glycol.
[0063] Figure 13 shows the measured optical density of the as-synthesized FAN in toluene and then converted to soluble in phosphate-buffered saline for normalized concentration. Similar phospholipid micelle encapsulation of CdSe-based semiconductor quantum dots for in vitro and in vivo imaging applications rendered them stable in physiological solution and non-toxic to cells up to concentrations of 5xlO9 per dots/cell.
CdSe/Au synthesis
[0064] Standard procedures were used to produce CdSe nanorods by reaction of Cd and Se precursors in trioctylphosphine oxide containing an alkylphosphonic acid. In the second step, Au precursors were added into the CdSe rod solution. The chemical difference of the two ends of the CdSe rods allows Au particles to be grown on one end preferentially by appropriate control of growth conditions.
CdSe rod synthesis procedure
[0065] Selenium was dissolved in prepared by dissolving selenium in trioctylphosphine (Se/trioctylphosphine) 10% w/w). Cadm ium oxide (200 mg), trioctylphosphine oxide (3 g), hexylphosphonic acid (0.16 g), and octadecylphosphonic acid (0.85 g) were heated to 330 0C in a flask under Ar on a
Schlenk line. Rapid injection of ~0.62g selenium/trioctylphosphine (10% w/w) at ~330°C into the flask causes fast nucleation of the rods. After 50 min at --3000C to promote further growth of the rods the reaction was stopped, the produced CdSe rods dissolved in toluene, precipitated by methanol, and then redissolved in toluene for storage.
[0066] The rods are characterized through use of transmission electron microscopy.
Varying the Se pre-cursor injection volume and concentration, the injection temperature, and the molar ratio of the trioctylphosphine oxide(TOPO):hexylphosphonic acid (HPA) :octadecylphosphonic acid (ODPA) allows control over the length and width of the rods. Typically increased Se precursor injection concentration and increased injection temperature leads to formation of larger number of nuclei, therefore the average size of the nanorods decreases. Increased molar ratio of phosphonic acids (HPA and ODPA) to TOPO leads to formation of nanorods of larger aspect ratio.
Au/CdSe nanocrystal metal-semiconductor junction synthesis procedure
[0067J The Au/CdSe nanocrystal semiconductor/metal junction was formed by growing Au tips on one end of the CdSe rods.
[0068] A stock solution of gold salts was prepared by dissolving AuCl3 (1.66 mg), didodecyldimethyl ammonium bromide (8.33 mg), and hexyldecylamine (15 mg) in toluene (1 g).
[0069] To CdSe rods (20 mg, synthesized as described above) diluted to 10 mg/mL with toluene under Ar was added ~1 mL of the stock solution of gold salts at a rate -0.1 mL/min. Owing to the chemical difference of the two ends of the CdSe rods, Au particles can be grown on one end preferentially. The thereby-produced Au/CdSe nanocrystal semiconductor/metal junctions were precipitated with methanol, and then redissolved in anhydrous toluene or chloroform for storage.
[0070] The as-synthesized Au/CdSe rods were characterized through use of transmission electron microscopy. The majority (>75%) of Au/CdSe rods synthesized by the procedure outline above are asymmetric with only a single Au tip on the CdSe rod.
CdSe/Au amphiphilic surface fnnctionalization
[0071] As synthesized, the CdSe/Au rods are covered by trioctylphosphine oxide and alkylphosphonic acid (both of which are hydrophobic), as shown in Figure 14. Surface functionalization covers the Au tips of the CdSe/Au rods with polyethylene glycol, making them hydrophilic; the CdSe end, still covered by trioctylphosphine oxide and alkyl phosphonic acid, remains hydrophobic (Figure 15). Overall the CdSe/Au nanojunctions are amphiphilic and compatible with bilipid membranes.
[0072] CdSe/Au (-0.1 mg/mL) nanojunctions are suspended in N,N- dimethylformamide containing detergent (e.g., 1% Triton X-IOO) and exposed to polyethylene glyco!-(CH2)ιo-SH (~1 mM) at room temperature for about an hour under stir to coordinate the thiol to the Au end. After the reaction, the Au/CdSe rods are separated from the solution through use of spin-filtration (filter pore size -1OkDa). The separated FANs are redissolved in phosphate buffered saline containing Triton X-IOO.
Construction of CdSe/Au containing Liposomes
[0073] Liposomes are prepared sonicating a commercially-available mixture of phosphatidyl choline/cholesterol/phosphatidyl glycerol/phosphatidyl inositol (in 8:10:1:1:2 molar ratio) in aqueous buffer (e.g., 20 mM sodium phosphate, 0.15 M NaCl, pH 7.4) at room temperature.
[0074] Amphiphilically functionalized CdSe/Au FANs are inserted into the liposomes through first de-stabilizing the preformed liposomes with a detergent (e.g., 1% Triton X-100), followed by addition of amphiphilic CdSe/Au FANs to the destabilized liposome suspension. The CdSe/Au FAN-containing liposomes are then reconstituted by gel-chromatography (through use of for example Sepharose 4B column in 20 mM sodium phosphate, 0.15 M NaCl, pH 7.4 buffer). The liposome size is characterized through use of dynamic light scattering, while the orientation and density of the FANs in the liposome are characterized through use of transmission electron microscopy.
Conjugation of antibody to the liposome
[0075] Selective delivery of liposomes to cells (e.g. retina ganglion cells) with specific surface receptors (e.g. retina ganglion cell specific Thy-1 receptor), is achieved by conjugating the liposome to the corresponding antibodies by the following procedure, in which the amine terminus of the heavy chain of the antibody is linked to the phosphatidyl glycerol component of the liposome via reductive amination-mediated conjugation technique as detailed in the following two steps.
Periodate oxidation of the phosphatidyl glycerol component of the liposomes
[0076] To a suspension of liposomes containing CdSe/Au rods diluted to total lipid
-5 mg/mL in buffer, and 200 μl of 0.6 M aqueous sodium periodate is added for each milliliter of the liposome suspension. After stirring for 30min at room temperature in the dark the oxidized liposomes are dialyzed against 20 mM sodium borate, 0.15 M NaCl pH 8.4 to remove the unreacted periodate. The liposome suspension is further purified through use of a column of Sephadex G-50.
Conjugation of periodate-oxidized liposomes to an antibody
[0077] To 1 mL of a liposome suspension containing ~5 mg/ml total lipid is added
0.5 mL of a solution of the antibody (e.g., anti-Thyl) dissolved in 20 mM sodium borate, 0.15 M NaCl, pH 8.4, at a concentration of -10 mg/mL. After incubation for 2 h at room temperature is added 10 μl of a 2 M solution of sodium cyanoborohydride in water, and reduction allowed to proceed at 4°C over-night. Gel filtration through a column of Sephadex G-50 removes unconjugated protein and excess cyanoborohydride from the liposome suspension.
Other Embodiments
[0078] The present invention clearly can be used to introduce photoresponsiveness to a wide variety of cells, and thereby not only to restore lost function but to impart new function to such cells. For example, through use of the present invention photoresponsiveness can be introduced to cells not normally responsive to light, and/or the range of photoresponsiveness can be extended beyond normally visible wavelengths (to, e.g., the near infrared).
Although the present invention has been described in terms of specific exemplary embodiments and examples, it will be appreciated that the embodiments disclosed herein are for illustrative purposes only and various modifications and alterations might be made by those skilled in the art without departing from the spirit and scope of the invention as set forth in the following claims.
Claims
1. A method of modulating photoreactivity in a cell, comprising: incorporating a functional abiotic nanosystem on the surface or in a membrane of the cell.
2. The method of claim 1, wherein the functional abiotic nanosystem is selected from the group consisting of nanometer-sized semiconductor/metal or semiconductor/semiconductor hetero-junctions.
3. The method of claim 2, wherein the functional abiotic nanosystem is a semiconductor/metal hetero-j unction.
4. The method of claim 3, wherein the nanometer-sized semiconductor/metal hetero- junction is formed between a metal and a semiconductor selected from group II-VI, IV, HI-V, IV-VI, metal-oxide, or organic semiconductors.
5. The method of claim 4} wherein the nanometer-sized semiconductor/metal hetero- junction is selected from the group consisting of CdSe/Au, Si/Au, GaAs/Au, InAs/Au, and PbS/Au hetero-junctions.
6. The method of claim 5, wherein the nanometer-sized semiconductor/metal hetero- junction is a CdSe/Au hetero-j unction.
7. The method of claim 1, wherein the functional abiotic nanosystem further comprises an amphiphilic coating.
8. The method of claim 1, wherein incorporation of the functional abiotic nanosystem with the cell is achieved through use of liposomes.
9. The method of claim 1, wherein the cell is a eukaryotic cell.
10. The method of claim 9, wherein the eukaryotic cell is from a mammal.
11. The method of claim 10, wherein the cell is selected from the group consisting of nerve cells, retinal ganglion cells, retinal bipolar cells, photoreceptor cells, and retinoblastoma cells.
12. The method of claim 11, wherein the cell is a retinal ganglion cell.
13. The method of claim 1, wherein the functional abiotic nanosystem responds to electromagnetic radiation.
14. The method of claim 13, wherein the electromagnetic radiation has a wavelength between about 200 nm and about 2000 nm.
15. The method of claim 14, wherein the electromagnetic radiation has a wavelength between about 350 nm and about 1000 nm.
16. The method of claim 15, wherein the electromagnetic radiation has a wavelength between about 400 nm and 800 nm.
17. The method of claim 1, wherein the membrane is selected from the group consisting of plasma membranes and organelle membranes.
18. The method of claim 17, wherein the membrane is a plasma membrane.
19. A eukaryotic cell comprising a functional abiotic nanosystem.
20. The cell of claim 19, wherein the functional abiotic nanosystem is selected from the group consisting of nanometer-sized semiconductor/metal or semiconductor/semiconductor hetero-junctions.
21. The cell of claim 20, wherein the functional abiotic nanosystem is a nanometer-sized semiconductor/metal hetero-junction .
22. The cell of claim 21, wherein the nanometer-sized semiconductor/metal hetero-junction is formed between a metal and a semiconductor selected from the group consisting of group II-VI, IV, III- V, IV-VI5 metal-oxide, or organic semiconductors.
23. The cell of claim 22, wherein the nanometer-sized semiconductor/metal hetero-junction is selected f>om the group consisting of CdSe/Au, Si/Au, GaAs/Au, InAs/Au, and PbS/Au hetero-junctions.
24. The cell of claim 23, wherein the nanometer-sized semiconductor/metal hetero-junction is a CdSe/Au hetero-junction.
25. The cell of claim 19, wherein the functional abiotic nanosystem further comprises an amphiphilic coating.
26. The cell of claim 19, wherein the cell is from a mammal.
27. The cell of claim 26, wherein the cell is selected from the group consisting of nerve cells, retinal ganglion cells, retinal bipolar cells, photoreceptor cells, and retinoblastoma cells.
28. The cell of claim 27, wherein the cell is a retinal ganglion cell.
29. The cell of claim 19, wherein the functional abiotic nanosystem responds to electromagnetic radiation.
30. The cell of claim 29, wherein the electromagnetic radiation has a wavelength between about 200 ran and about 2000 nm.
31. The cell of claim 30, wherein the electromagnetic radiation has a wavelength between about 350 nm and about 1000 nm.
32. The cell of claim 31, wherein the electromagnetic radiation has a wavelength between about 400 nm and 800 nm.
33. A method for endowing/recovering photosensitivity in an optic nerve cell, comprising: introducing a functional abiotic nanosystem to the cell, wherein said functional abiotic nanosystem comprises a nanometer-sized semiconductor/metal or semiconductor/semiconductor hetero-junctions.
34. The method of claim 33, wherein said introducing step comprises encapsulating the functional abiotic nanosystem in a liposome and fusing the liposome with the cell.
5. A photoresponsive functional abiotic nanosystem, comprising: a nanometer-sized particle having a semiconductor end linked to a metal end or a heterologous semiconductor; and a plurality of functional groups attached to the surface of the nanometer-sized particle, wherein when the functional abiotic nanosystem is inserted in the membrane of a cell, the nanometer-sized particle is capable of generating a photovoltage that can depolarize the membrane.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94336007P | 2007-06-12 | 2007-06-12 | |
US60/943,360 | 2007-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008154645A1 true WO2008154645A1 (en) | 2008-12-18 |
Family
ID=40130221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/066783 WO2008154645A1 (en) | 2007-06-12 | 2008-06-12 | Functional abiotic nanosystems |
Country Status (2)
Country | Link |
---|---|
US (1) | US8399751B2 (en) |
WO (1) | WO2008154645A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2793997A4 (en) * | 2011-11-30 | 2015-11-25 | Neuronano Ab | Nanowire-based devices for light-induced and electrical stimulation of biological cells |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8602959B1 (en) | 2010-05-21 | 2013-12-10 | Robert Park | Methods and devices for delivery of radiation to the posterior portion of the eye |
ES2432665T3 (en) | 2008-01-07 | 2013-12-04 | Salutaris Medical Devices, Inc. | Devices for minimally invasive extraocular administration of radiation to the posterior portion of the eye |
US10022558B1 (en) | 2008-01-07 | 2018-07-17 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
US9056201B1 (en) | 2008-01-07 | 2015-06-16 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
US8608632B1 (en) | 2009-07-03 | 2013-12-17 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive extraocular delivery of radiation and/or pharmaceutics to the posterior portion of the eye |
US9873001B2 (en) | 2008-01-07 | 2018-01-23 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
USD691268S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to eye |
USD691270S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to an eye |
USD691267S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to eye |
USD691269S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to an eye |
EP2496304A4 (en) * | 2009-11-02 | 2013-04-17 | Salutaris Medical Devices Inc | Methods and devices for delivering appropriate minimally-invasive extraocular radiation |
US20130112942A1 (en) | 2011-11-09 | 2013-05-09 | Juanita Kurtin | Composite having semiconductor structures embedded in a matrix |
US20130112941A1 (en) * | 2011-11-09 | 2013-05-09 | Juanita Kurtin | Semiconductor structure having nanocrystalline core and nanocrystalline shell with insulator coating |
JP5892671B2 (en) * | 2012-08-01 | 2016-03-23 | 国立研究開発法人産業技術総合研究所 | Bonded structure of rock salt type oxide nanoparticles having cubic shape or quadrangular prism shape and fine metal particles, and method for producing the same |
US9425365B2 (en) | 2012-08-20 | 2016-08-23 | Pacific Light Technologies Corp. | Lighting device having highly luminescent quantum dots |
US8889457B2 (en) | 2012-12-13 | 2014-11-18 | Pacific Light Technologies Corp. | Composition having dispersion of nano-particles therein and methods of fabricating same |
WO2017049125A1 (en) | 2015-09-16 | 2017-03-23 | La Jolla Nanomedical | A cellular activity targeted nanoparticle system and methods of producing the nanoparticle system |
USD814637S1 (en) | 2016-05-11 | 2018-04-03 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD814638S1 (en) | 2016-05-11 | 2018-04-03 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD815285S1 (en) | 2016-05-11 | 2018-04-10 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD808529S1 (en) | 2016-08-31 | 2018-01-23 | Salutaris Medical Devices, Inc. | Holder for a brachytherapy device |
USD808528S1 (en) | 2016-08-31 | 2018-01-23 | Salutaris Medical Devices, Inc. | Holder for a brachytherapy device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060113557A1 (en) * | 2004-11-30 | 2006-06-01 | Spire Corporation | Nanophotovoltaic devices |
US20070028928A1 (en) * | 2005-08-05 | 2007-02-08 | Peyman Gholam A | Methods to regulate polarization of excitable cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194213B1 (en) * | 1999-12-10 | 2001-02-27 | Bio-Pixels Ltd. | Lipophilic, functionalized nanocrystals and their use for fluorescence labeling of membranes |
US20020127224A1 (en) * | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
AU2002316347A1 (en) * | 2001-06-22 | 2003-01-08 | Ut-Battelle, Llc | Modulating photoreactivity in a cell |
WO2006037226A1 (en) * | 2004-10-05 | 2006-04-13 | Mcgill University | Use of quantum dots for biological labels and sensors |
JP2008532522A (en) * | 2005-03-08 | 2008-08-21 | モレキュラー プローブス, インコーポレイテッド | Monitoring and manipulating cell membrane potential differences using nanostructures |
-
2008
- 2008-06-12 US US12/138,289 patent/US8399751B2/en active Active
- 2008-06-12 WO PCT/US2008/066783 patent/WO2008154645A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060113557A1 (en) * | 2004-11-30 | 2006-06-01 | Spire Corporation | Nanophotovoltaic devices |
US20070028928A1 (en) * | 2005-08-05 | 2007-02-08 | Peyman Gholam A | Methods to regulate polarization of excitable cells |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2793997A4 (en) * | 2011-11-30 | 2015-11-25 | Neuronano Ab | Nanowire-based devices for light-induced and electrical stimulation of biological cells |
Also Published As
Publication number | Publication date |
---|---|
US20090088843A1 (en) | 2009-04-02 |
US8399751B2 (en) | 2013-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8399751B2 (en) | Functional abiotic nanosystems | |
CA2716991C (en) | Method for stimulating retinal response using photoactive devices | |
EP2793997B1 (en) | Nanowire-based devices for light-induced and electrical stimulation of biological cells | |
US9956425B2 (en) | Methods to regulate polarization and enhance function of cells | |
EP2582324B1 (en) | Ultra-high photosensitivity vertical nanowire arrays for retinal prosthesis | |
Pinaud et al. | Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides | |
Bareket-Keren et al. | Novel interfaces for light directed neuronal stimulation: advances and challenges | |
US20140336514A1 (en) | Methods to regulate polarization and enhance function of cells | |
US20150283265A1 (en) | Methods to regulate polarization and enhance function of cells | |
US20150182756A1 (en) | Methods to regulate polarization and enhance function of cells | |
De Leo et al. | Hybrid assemblies of fluorescent nanocrystals and membrane proteins in liposomes | |
AU2018360637A1 (en) | Metal nanoparticles and methods of making same | |
Vyas et al. | Liposomes based nasal delivery system of nifedipine: Development and characterization | |
US8774936B2 (en) | Photoelectrical devices for stimulating neurons | |
US20150119794A1 (en) | Methods to regulate polarization and enhance function of cells | |
Melikov et al. | Plasmon-coupled photocapacitor neuromodulators | |
Bondelli et al. | Shedding light on thermally induced optocapacitance at the organic biointerface | |
Martinez‐Avila et al. | Self‐assembly of amelogenin proteins at the water–oil interface | |
Ronzani et al. | High‐frequency stimulation of normal and blind mouse retinas using TiO2 nanotubes | |
Khraiche et al. | Ultra-high photosensitivity silicon nanophotonics for retinal prosthesis: electrical characteristics | |
WO2017117217A1 (en) | Penetratable retinal ships for treating impaired vision | |
Glaser | Electric properties of the membrane and the cell surface | |
Pagar et al. | CUBOSOME: INNOVATIVE NANOSTRUCTURES FOR DRUG DELIVERY. | |
Chatterjee et al. | Microviscosity-Assisted Disaggregation of a Model Ophthalmic Drug and FRET-Controlled Singlet Oxygen Generation in Lyotropic Liquid Crystals | |
DOLTCHINKOVA et al. | Modulation of membrane electrokinetic properties by semiconductor nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08770898 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |
Ref document number: 08770898 Country of ref document: EP Kind code of ref document: A1 |